Genemakers’ Clinical Testing Specialist, Stephanie Wheeler, was interviewed by Thermo Fisher Scientific to discuss pharmacogenomic (PGx) testing, its benefits, and how to implement a PGx testing program.
Using Thermo Fisher Scientific’s state-of-the-art real-time qPCR technologies, Genemarkers offers high-quality PGx testing services rooted in clinical validity/utility.
“From the beginning, we have performed our PGx testing using qPCR due to the flexibility and efficient workflow for processing the samples. The format allows us to customize the genes and variants that we analyze and test multiple samples at the same time,” says Wheeler.
Our tests follow guidelines set by the Food and Drug Administration (FDA), Clinical Pharmacogenomics Implementation Consortium (CPIC), and other regulatory bodies that determine clinical utility and validity based on scientific evidence. Currently, Genemarkers offers three multigene PGx panels and two single gene tests to meet the diverse needs of our clients.